INTS
Income statement / Annual
Last year (2025), Intensity Therapeutics Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Intensity Therapeutics Inc's net income was -$11.61 M.
See Intensity Therapeutics Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$26.00 K
|
$0.00
|
$147.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$26.00 K
|
$0.00
|
-$147.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$6.79 M
|
$10.50 M
|
$4.79 M
|
$5.13 M
|
$5.86 M
|
$5.05 M
|
$4.44 M
|
| General & Administrative Expenses |
$5.19 M
|
$6.09 M
|
$3.53 M
|
$2.42 M
|
$2.14 M
|
$1.17 M
|
$1.24 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
-$147.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$5.19 M
|
$6.09 M
|
$3.39 M
|
$2.42 M
|
$2.14 M
|
$1.17 M
|
$1.24 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$17.22 K
|
$0.00
|
$0.00
|
| Operating Expenses |
$11.97 M
|
$16.59 M
|
$8.17 M
|
$7.55 M
|
$8.01 M
|
$6.22 M
|
$5.68 M
|
| Cost And Expenses |
$11.97 M
|
$16.59 M
|
$8.32 M
|
$7.55 M
|
$8.01 M
|
$6.22 M
|
$5.68 M
|
| Interest Income |
$180.00 K
|
$314.00 K
|
$324.00 K
|
$2.48 K
|
$2.61 K
|
$74.01 K
|
$150.71 K
|
| Interest Expense |
$0.00
|
$0.00
|
$305.00 K
|
$81.78 K
|
$16.77 K
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$0.00
|
$147.00 K
|
$0.00
|
$0.00
|
$0.00
|
$171.86 K
|
| EBITDA |
-$11.97 M |
-$16.27 M |
-$10.09 M |
-$7.50 M |
-$7.88 M |
-$6.03 M |
-$5.21 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$366.00 K
|
$317.00 K
|
-$2.22 M
|
-$32.00 K
|
$118.58 K
|
$192.77 K
|
$295.70 K
|
| Income Before Tax |
-$11.61 M
|
-$16.27 M
|
-$10.54 M
|
-$7.58 M
|
-$7.90 M
|
-$6.03 M
|
-$5.38 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$11.61 M
|
-$16.27 M
|
-$10.54 M
|
-$7.58 M
|
-$7.90 M
|
-$5.96 M
|
-$5.23 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-8.56 |
-29.25 |
-34.5 |
-55.5 |
-58 |
-44.25 |
-39.5 |
| EPS Diluted |
-8.56 |
-29.25 |
-34.5 |
-55.5 |
-58 |
-44.25 |
-39.5 |
| Weighted Average Shares Out |
$13.56 M
|
$556.24 K
|
$306.16 K
|
$136.40 K
|
$136.40 K
|
$136.36 K
|
$136.08 K
|
| Weighted Average Shares Out Diluted |
$13.56 M
|
$556.28 K
|
$344.65 K
|
$136.40 K
|
$136.40 K
|
$136.38 K
|
$136.12 K
|
| Link |
|
|
|
|
|
|
|
